baclofen and zolpidem

baclofen has been researched along with zolpidem in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cornali, C; Di Fazio, I; Fisoni, GB; Franzooni, S; Gatti, S; Respini, C; Riello, R; Stofler, PM; Trabucchi, M1
Hutson, PH; McDonald, LM; Sheppard, WF; Sohal, B; Staveley, SM; Tattersall, FD1
Clauss, RP2
Chroni, E; Constantoyannis, C; Ellul, J; Georgiopoulos, M; Katsakiori, P; Kefalopoulou, Z1
Kotak, VC; MacKenzie, PC; Sanes, DH; Takesian, AE1
Ando, T; Horisawa, S; Kawamata, T; Taira, T1

Reviews

3 review(s) available for baclofen and zolpidem

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Vegetative state and minimally conscious state: a review of the therapeutic interventions.
    Stereotactic and functional neurosurgery, 2010, Volume: 88, Issue:4

    Topics: Baclofen; Consciousness; Electric Stimulation Therapy; Humans; Persistent Vegetative State; Pyridines; Treatment Outcome; Zolpidem

2010
Neurotransmitters in disorders of consciousness and brain damage.
    Medical hypotheses, 2011, Volume: 77, Issue:2

    Topics: Antidepressive Agents, Tricyclic; Axons; Baclofen; Consciousness Disorders; Dopamine Agents; Electric Stimulation; Humans; Models, Biological; Neurotransmitter Agents; Oxygen; Pyridines; Synapses; Zolpidem

2011

Other Studies

7 other study(ies) available for baclofen and zolpidem

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Charles Bonnet syndrome and GABAergic drugs--a case report.
    Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:4

    Topics: Aged; Aged, 80 and over; Baclofen; Causality; Drug Interactions; Female; GABA Agonists; Hallucinations; Humans; Mental Status Schedule; Pyridines; Syndrome; Zolpidem

2004
Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats.
    Psychopharmacology, 2008, Volume: 197, Issue:4

    Topics: Administration, Oral; Amines; Animals; Anticonvulsants; Azabicyclo Compounds; Baclofen; Benzodiazepines; Bicuculline; Brain; Cyclohexanecarboxylic Acids; Discrimination Learning; Dose-Response Relationship, Drug; GABA Agents; GABA Agonists; GABA Antagonists; GABA Plasma Membrane Transport Proteins; Gabapentin; gamma-Aminobutyric Acid; Generalization, Stimulus; Hypnotics and Sedatives; Injections, Intraperitoneal; Isoxazoles; Male; Nipecotic Acids; Piperazines; Pyridines; Rats; Thiophenes; Tiagabine; Zolpidem

2008
Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions.
    Medical hypotheses, 2010, Volume: 75, Issue:3

    Topics: Antidepressive Agents, Tricyclic; Baclofen; Coma; Dopamine Agents; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Models, Biological; Neurotransmitter Agents; Persistent Vegetative State; Pyridines; Zolpidem

2010
Rescue of inhibitory synapse strength following developmental hearing loss.
    PloS one, 2013, Volume: 8, Issue:1

    Topics: Animals; Baclofen; Cochlea; GABA Uptake Inhibitors; GABA-A Receptor Agonists; Gerbillinae; Hearing Loss; Inhibitory Postsynaptic Potentials; Neural Inhibition; Pyridines; Receptors, GABA-A; Synapses; Zolpidem

2013
Complex regional pain syndrome after mRNA-based COVID-19 vaccination.
    Clinical neurology and neurosurgery, 2023, Volume: 224

    Topics: Adolescent; Baclofen; Complex Regional Pain Syndromes; COVID-19; COVID-19 Vaccines; Female; Humans; Vaccination; Zolpidem

2023